Arvinas, Inc. (ARVN)
12.99
-0.11
(-0.84%)
USD |
NASDAQ |
Dec 10, 16:00
12.99
0.00 (0.00%)
After-Hours: 16:22
Arvinas Total Assets (Quarterly): 844.30M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| Assembly Biosciences, Inc. | 240.00M |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Verastem, Inc. | 176.85M |
| Sarepta Therapeutics, Inc. | 3.493B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 279.90M |
| Shareholders Equity (Quarterly) | 564.40M |
| Debt to Equity Ratio | 0.0168 |
| Current Ratio | 5.703 |
| Net Debt Paydown Yield | -0.24% |